.png)
Cold And Flu Supplements Market by Product Type - Global Industry Analysis & Forecast to 2027
Published On : August 2020 Pages : 170 Category: Pharma & Healthcare Report Code : HC0812484
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Cold And Flu Supplements Market by Product Type (Natural Molecules, Herbal Extracts, Vitamins & Minerals)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Cold And Flu Supplements Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Vitamin C can reduce the duration of colds, but only if been supplementing regularly. Zinc plays many roles in the body including several in the immune system alone.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- WAKUNAGA OF AMERICA CO., LTD.
- Neurobiologix, Inc.
- The Vitamin Shoppe
- KLAIRE LABS
- Nordic Naturals
- Himalaya Global Holdings Ltd.
- Nature's Way Products, LLC (Dr. Willmar Schwabe GmbH & Co. KG)
- FineVine
- Flora Inc.
- Pfizer Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Cold And Flu Supplements Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Natural Molecules
o Herbal Extracts
o Vitamins & Minerals
· Cold And Flu Supplements Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o WAKUNAGA OF AMERICA CO., LTD.
o Neurobiologix, Inc.
o The Vitamin Shoppe
o KLAIRE LABS
o Nordic Naturals
o Himalaya Global Holdings Ltd.
o Nature's Way Products, LLC (Dr. Willmar Schwabe GmbH & Co. KG)
o FineVine
o Flora Inc.
o Pfizer Inc.
· Cold And Flu Supplements Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Cold And Flu Supplements Market , By Country
o U.S. Cold And Flu Supplements Market
o Canada Cold And Flu Supplements Market
o Mexico Cold And Flu Supplements Market
o Europe
§ Europe Cold And Flu Supplements Market , By Country
o Germany Cold And Flu Supplements Market
o UK Cold And Flu Supplements Market
o France Cold And Flu Supplements Market
o Russia Cold And Flu Supplements Market
o Italy Cold And Flu Supplements Market
o Rest of Europe Cold And Flu Supplements Market
o Asia-Pacific
§ Asia-Pacific Cold And Flu Supplements Market , By Country
o China Cold And Flu Supplements Market
o Japan Cold And Flu Supplements Market
o South Korea Cold And Flu Supplements Market
o India Cold And Flu Supplements Market
o Southeast Asia Cold And Flu Supplements Market
o Rest of Asia-Pacific Cold And Flu Supplements Market
o South America
§ South America Cold And Flu Supplements Market , By Country
o Brazil Cold And Flu Supplements Market
o Argentina Cold And Flu Supplements Market
o Columbia Cold And Flu Supplements Market
o Rest of South America Cold And Flu Supplements Market
o Middle East and Africa
§ Middle East and Africa Cold And Flu Supplements Market , By Country
o Saudi Arabia Cold And Flu Supplements Market
o UAE Cold And Flu Supplements Market
o Egypt Cold And Flu Supplements Market
o Nigeria Cold And Flu Supplements Market
o South Africa Cold And Flu Supplements Market
o Rest of MEA Cold And Flu Supplements Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Cold And Flu Supplements Market, By Product Type
5.1. Introduction
5.2. Global Cold And Flu Supplements Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Cold And Flu Supplements Revenue and Revenue Share by Product Type (2017-2021)
5.3. Natural Molecules
5.3.1. Global Natural Molecules Revenue and Growth Rate (2017-2021)
5.4. Herbal Extracts
5.4.1. Global Herbal Extracts Revenue and Growth Rate (2017-2021)
5.5. Vitamins & Minerals
5.5.1. Global Vitamins & Minerals Revenue and Growth Rate (2017-2021)
6. Cold And Flu Supplements Market, By Region
6.1. Introduction
6.2. Global Cold And Flu Supplements Revenue and Market Share by Regions
6.2.1. Global Cold And Flu Supplements Revenue by Regions (2017-2021)
6.3. North America Cold And Flu Supplements by Countries
6.3.1. North America Cold And Flu Supplements Revenue and Growth Rate (2017-2021)
6.3.2. North America Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2021)
6.3.3. United States
6.3.3.1. United States Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.3.4. Canada
6.3.4.1. Canada Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.3.5. Mexico
6.3.5.1. Mexico Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.4. Europe Cold And Flu Supplements by Countries
6.4.1. Europe Cold And Flu Supplements Revenue and Growth Rate (2017-2021)
6.4.2. Europe Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2021)
6.4.3. Germany
6.4.3.1. Germany Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.4. France
6.4.4.1. France Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.5. UK
6.4.5.1. UK Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.6. Russia
6.4.6.1. Russia Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.7. Italy
6.4.7.1. Italy Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.5. Asia-Pacific Cold And Flu Supplements by Countries
6.5.1. Asia-Pacific Cold And Flu Supplements Revenue and Growth Rate (2017-2021)
6.5.2. Asia-Pacific Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2021)
6.5.3. China
6.5.3.1. China Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.4. Japan
6.5.4.1. Japan Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.5. Korea
6.5.5.1. Korea Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.6. India
6.5.6.1. India Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.6. South America Cold And Flu Supplements by Countries
6.6.1. South America Cold And Flu Supplements Revenue and Growth Rate (2017-2021)
6.6.2. South America Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2021)
6.6.3. Brazil
6.6.3.1. Brazil Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.4. Argentina
6.6.4.1. Argentina Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.5. Columbia
6.6.5.1. Columbia Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.7. Middle East and Africa Cold And Flu Supplements by Countries
6.7.1. Middle East and Africa Cold And Flu Supplements Revenue and Growth Rate (2017-2021)
6.7.2. Middle East and Africa Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2021)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.5. Egypt
6.7.5.1. Egypt Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.6. Nigeria
6.7.6.1. Nigeria Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.7. South Africa
6.7.7.1. South Africa Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.8. Turkey
6.7.8.1. Turkey Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2021)
7. Company Profiles
7.1. WAKUNAGA OF AMERICA CO., LTD.
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. Neurobiologix, Inc.
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. The Vitamin Shoppe
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. KLAIRE LABS
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
7.5. Nordic Naturals
7.5.1. Business Overview
7.5.2. Service Portfolio
7.5.3. Strategic Developments
7.5.4. Financial Overview
7.6. Himalaya Global Holdings Ltd.
7.6.1. Business Overview
7.6.2. Service Portfolio
7.6.3. Strategic Developments
7.6.4. Financial Overview
7.7. Nature's Way Products, LLC (Dr. Willmar Schwabe GmbH & Co. KG)
7.7.1. Business Overview
7.7.2. Service Portfolio
7.7.3. Strategic Developments
7.7.4. Financial Overview
7.8. FineVine
7.8.1. Business Overview
7.8.2. Service Portfolio
7.8.3. Strategic Developments
7.8.4. Financial Overview
7.9. Flora Inc.
7.9.1. Business Overview
7.9.2. Service Portfolio
7.9.3. Strategic Developments
7.9.4. Financial Overview
7.10. Pfizer Inc.
7.10.1. Business Overview
7.10.2. Service Portfolio
7.10.3. Strategic Developments
7.10.4. Financial Overview
8. Cold And Flu Supplements Market Forecast (2022-2027)
8.1. Global Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2022-2027)
8.2. Cold And Flu Supplements Market Forecast by Regions (2022-2027)
8.2.1. North America Cold And Flu Supplements Market Forecast (2022-2027)
8.2.1.1. United States Cold And Flu Supplements Market Forecast (2022-2027)
8.2.1.2. Canada Cold And Flu Supplements Market Forecast (2022-2027)
8.2.1.3. Mexico Cold And Flu Supplements Market Forecast (2022-2027)
8.2.2. Europe Cold And Flu Supplements Market Forecast (2022-2027)
8.2.2.1. Germany Cold And Flu Supplements Market Forecast (2022-2027)
8.2.2.2. France Cold And Flu Supplements Market Forecast (2022-2027)
8.2.2.3. UK Cold And Flu Supplements Market Forecast (2022-2027)
8.2.2.4. Russia Cold And Flu Supplements Market Forecast (2022-2027)
8.2.2.5. Italy Cold And Flu Supplements Market Forecast (2022-2027)
8.2.2.6. Rest of Europe Cold And Flu Supplements Market Forecast (2022-2027)
8.2.3. Asia-Pacific Cold And Flu Supplements Market Forecast (2022-2027)
8.2.3.1. China Cold And Flu Supplements Market Forecast (2022-2027)
8.2.3.2. Japan Cold And Flu Supplements Market Forecast (2022-2027)
8.2.3.3. Korea Cold And Flu Supplements Market Forecast (2022-2027)
8.2.3.4. India Cold And Flu Supplements Market Forecast (2022-2027)
8.2.3.5. Southeast Asia Cold And Flu Supplements Market Forecast (2022-2027)
8.2.3.6. Rest of Asia-Pacific Cold And Flu Supplements Market Forecast (2022-2027)
8.2.4. South America Cold And Flu Supplements Market Forecast (2022-2027)
8.2.4.1. Brazil Cold And Flu Supplements Market Forecast (2022-2027)
8.2.4.2. Argentina Cold And Flu Supplements Market Forecast (2022-2027)
8.2.4.3. Columbia Cold And Flu Supplements Market Forecast (2022-2027)
8.2.4.4. Rest of South America Cold And Flu Supplements Market Forecast (2022-2027)
8.2.5. Middle East and Africa Cold And Flu Supplements Market Forecast (2022-2027)
8.2.5.1. Saudi Arabia Cold And Flu Supplements Market Forecast (2022-2027)
8.2.5.2. United Arab Emirates Cold And Flu Supplements Market Forecast (2022-2027)
8.2.5.3. Egypt Cold And Flu Supplements Market Forecast (2022-2027)
8.2.5.4. Nigeria Cold And Flu Supplements Market Forecast (2022-2027)
8.2.5.5. South Africa Cold And Flu Supplements Market Forecast (2022-2027)
8.2.5.6. Turkey Cold And Flu Supplements Market Forecast (2022-2027)
8.2.5.7. Rest of Middle East and Africa Cold And Flu Supplements Market Forecast (2022-2027)
8.3. Cold And Flu Supplements Market Forecast by Product Type (2022-2027)
8.3.1. Cold And Flu Supplements Forecast by Product Type (2022-2027)
8.3.2. Cold And Flu Supplements Market Share Forecast by Product Type (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Cold And Flu Supplements Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Cold And Flu Supplements Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Natural Molecules Revenue and Growth Rate (2017-2019)
Figure Global Herbal Extracts Revenue and Growth Rate (2017-2019)
Figure Global Vitamins & Minerals Revenue and Growth Rate (2017-2019)
Table Global Cold And Flu Supplements Revenue by Regions (2017-2019)
Figure North America Cold And Flu Supplements Growth Rate (2017-2019)
Figure North America Cold And Flu Supplements Revenue and Growth Rate (2017-2019)
Figure North America Cold And Flu Supplements by Countries (2017-2019)
Figure North America Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2019)
Figure United States Cold And Flu Supplements Growth Rate (2017-2019)
Figure United States Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Cold And Flu Supplements Growth Rate (2017-2019)
Figure Canada Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Cold And Flu Supplements Growth Rate (2017-2019)
Figure Mexico Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Cold And Flu Supplements Growth Rate (2017-2019)
Figure Europe Cold And Flu Supplements Revenue and Growth Rate (2017-2019)
Figure Europe Cold And Flu Supplements by Countries (2017-2019)
Figure Europe Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2019)
Figure Germany Cold And Flu Supplements Growth Rate (2017-2019)
Figure Germany Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Cold And Flu Supplements Growth Rate (2017-2019)
Figure France Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Cold And Flu Supplements Growth Rate (2017-2019)
Figure UK Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Cold And Flu Supplements Growth Rate (2017-2019)
Figure Russia Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Cold And Flu Supplements Growth Rate (2017-2019)
Figure Italy Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Cold And Flu Supplements Growth Rate (2017-2019)
Figure Rest of Europe Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Cold And Flu Supplements Growth Rate (2017-2019)
Figure Asia-Pacific Cold And Flu Supplements Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Cold And Flu Supplements by Countries (2017-2019)
Figure Asia-Pacific Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2019)
Figure China Cold And Flu Supplements Growth Rate (2017-2019)
Figure China Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Cold And Flu Supplements Growth Rate (2017-2019)
Figure Japan Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Cold And Flu Supplements Growth Rate (2017-2019)
Figure Korea Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Cold And Flu Supplements Growth Rate (2017-2019)
Figure India Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Cold And Flu Supplements Growth Rate (2017-2019)
Figure Southeast Asia Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Cold And Flu Supplements Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Cold And Flu Supplements Growth Rate (2017-2019)
Figure South America Cold And Flu Supplements Revenue and Growth Rate (2017-2019)
Figure South America Cold And Flu Supplements by Countries (2017-2019)
Figure South America Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Cold And Flu Supplements Growth Rate (2017-2019)
Figure Brazil Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Cold And Flu Supplements Growth Rate (2017-2019)
Figure Argentina Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Cold And Flu Supplements Growth Rate (2017-2019)
Figure Columbia Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Cold And Flu Supplements Growth Rate (2017-2019)
Figure Rest of South America Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Cold And Flu Supplements Growth Rate (2017-2019)
Figure Middle East and Africa Cold And Flu Supplements Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Cold And Flu Supplements by Countries (2017-2019)
Figure Middle East and Africa Cold And Flu Supplements Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Cold And Flu Supplements Growth Rate (2017-2019)
Figure Saudi Arabia Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Cold And Flu Supplements Growth Rate (2017-2019)
Figure United Arab Emirates Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Cold And Flu Supplements Growth Rate (2017-2019)
Figure Egypt Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Cold And Flu Supplements Growth Rate (2017-2019)
Figure Nigeria Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Cold And Flu Supplements Growth Rate (2017-2019)
Figure South Africa Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Cold And Flu Supplements Growth Rate (2017-2019)
Figure Turkey Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Cold And Flu Supplements Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2017-2019)
Table WAKUNAGA OF AMERICA CO., LTD. Cold And Flu Supplements Financial Overview
Table Neurobiologix, Inc. Cold And Flu Supplements Financial Overview
Table The Vitamin Shoppe Cold And Flu Supplements Financial Overview
Table KLAIRE LABS Cold And Flu Supplements Financial Overview
Table Nordic Naturals Cold And Flu Supplements Financial Overview
Table Himalaya Global Holdings Ltd. Cold And Flu Supplements Financial Overview
Table Nature's Way Products, LLC (Dr. Willmar Schwabe GmbH & Co. KG) Cold And Flu Supplements Financial Overview
Table FineVine Cold And Flu Supplements Financial Overview
Table Flora Inc. Cold And Flu Supplements Financial Overview
Table Pfizer Inc. Cold And Flu Supplements Financial Overview
Figure Global Cold And Flu Supplements Revenue (Millions USD) and Growth Rate (2019-2027)
Table Cold And Flu Supplements Market Forecast by Regions (2019-2027)
Figure North America Cold And Flu Supplements Market Forecast (2019-2027)
Figure United States Cold And Flu Supplements Market Forecast (2019-2027)
Figure Canada Cold And Flu Supplements Market Forecast (2019-2027)
Figure Mexico Cold And Flu Supplements Market Forecast (2019-2027)
Figure Europe Cold And Flu Supplements Market Forecast (2019-2027)
Figure Germany Cold And Flu Supplements Market Forecast (2019-2027)
Figure France Cold And Flu Supplements Market Forecast (2019-2027)
Figure UK Cold And Flu Supplements Market Forecast (2019-2027)
Figure Russia Cold And Flu Supplements Market Forecast (2019-2027)
Figure Italy Cold And Flu Supplements Market Forecast (2019-2027)
Figure Rest of Europe Cold And Flu Supplements Market Forecast (2019-2027)
Figure Asia-Pacific Cold And Flu Supplements Market Forecast (2019-2027)
Figure China Cold And Flu Supplements Market Forecast (2019-2027)
Figure Japan Cold And Flu Supplements Market Forecast (2019-2027)
Figure Korea Cold And Flu Supplements Market Forecast (2019-2027)
Figure India Cold And Flu Supplements Market Forecast (2019-2027)
Figure Southeast Asia Cold And Flu Supplements Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Cold And Flu Supplements Market Forecast (2019-2027)
Figure South America Cold And Flu Supplements Market Forecast (2019-2027)
Figure Brazil Cold And Flu Supplements Market Forecast (2019-2027)
Figure Argentina Cold And Flu Supplements Market Forecast (2019-2027)
Figure Columbia Cold And Flu Supplements Market Forecast (2019-2027)
Figure Rest of South America Cold And Flu Supplements Market Forecast (2019-2027)
Figure Middle East and Africa Cold And Flu Supplements Market Forecast (2019-2027)
Figure Saudi Arabia Cold And Flu Supplements Market Forecast (2019-2027)
Figure United Arab Emirates Cold And Flu Supplements Market Forecast (2019-2027)
Figure Egypt Cold And Flu Supplements Market Forecast (2019-2027)
Figure Nigeria Cold And Flu Supplements Market Forecast (2019-2027)
Figure South Africa Cold And Flu Supplements Market Forecast (2019-2027)
Figure Turkey Cold And Flu Supplements Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Cold And Flu Supplements Market Forecast (2019-2027)
Figure Global Cold And Flu Supplements Forecast by Product Type (2019-2027)
Figure Global Cold And Flu Supplements Market Share Forecast by Product Type (2019-2027)
Figure Global Cold And Flu Supplements Forecast by Product Type (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|